Track StemGen's total current liabilities ($1.9M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2022), SGNI shows a total current liabilities of $1.9M. That compares with $1.7M in the prior-year period — up 11.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SGNI's total current liabilities is now $1.9M (was $1.7M) — a 11.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether StemGen is outperforming or lagging.
Tracking SGNI's total current liabilities over time shows whether StemGen is scaling, shrinking, or reshaping that part of the business. The current reading is $1.9M That compares with $1.7M in the prior-year period — up 11.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total current liabilities page, Stockcircle has StemGen's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $1.9M) with ownership activity and broader fundamentals.